Acuta Capital Partners’s Oculis Holding OCS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-98,339
Closed -$2.61M 26
2026
Q1
$2.61M Sell
98,339
-3,438
-3% -$91K 1.84% 14
2025
Q4
$2.03M Hold
101,777
1.38% 17
2025
Q3
$1.79M Sell
101,777
-4,941
-5% -$87.6K 1.85% 16
2025
Q2
$2.07M Sell
106,718
-18,282
-15% -$336K 2.89% 12
2025
Q1
$2.38M Buy
+125,000
New +$2.56M 2.76% 12

Other funds holding OCS

Acuta Capital Partners's OCS Position: Q2 2026 in Review

Acuta Capital Partners sold out of Oculis Holding (OCS) in Q2 2026, closing a stake of 98,339 shares — an estimated $2.61M sold.

Acuta Capital Partners first reported a position in OCS in Q1 2025 and held it in 5 quarters. The position peaked at $2.61M in Q1 2026. 59 funds tracked by Wall St. Rank hold OCS as of Q2 2026.

  • Acuta Capital Partners reported no remaining Oculis Holding position as of Q2 2026 after selling out during the quarter.
  • Acuta Capital Partners sold 98,339 Oculis Holding shares in Q2 2026, an estimated $2.61M.
  • Acuta Capital Partners first reported a position in Oculis Holding in Q1 2025 and held it in 5 quarters.
  • Acuta Capital Partners's Oculis Holding position peaked at $2.61M in Q1 2026.
  • 59 funds tracked by Wall St. Rank held Oculis Holding as of Q2 2026.

Based on Acuta Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.